Profil bibliographique

Ben Spittle

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

12Publications signalées

105Citations signalées

3Affiliations récentes

Institutions déclarées

MRC Clinical Trials Unit at UCL University College London Medical Research Council

Domaines associés

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentProstate Cancer Treatment and ResearchHIV-related health complications and treatmentsHIV Research and Treatment

Publications récentes

Accès ouvert 2026 articleOpenAlex

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial

Julia Bielicki, Michelle Clements, Victor Musiime, David P. Moore et autres

3 citationsThe Lancet

Accès ouvert 2026 articleOpenAlex

Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial

Adeodata Kekitiinwa, Angus Jennings, Mutsa Bwakura-Dangarembizi, Cissy Kityo et autres

0 citationsThe Lancet HIV

Accès ouvert 2026 articleOpenAlex

Trial design and enrolment characteristics of LATA (long-acting treatment in adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to

Diana Anena, Elizabeth Chappell, Rashidah Nazzinda, Cecilia Kiilu et autres

0 citationsWhite Rose Research Online (University of Leeds, The University of Sheffield, University of York)

Accès ouvert 2026 articleOpenAlex

Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa

Diana Anena, Elizabeth Chappell, Rashidah Nazzinda, Cecilia Kiilu et autres

1 citationContemporary Clinical Trials

2026 articleOpenAlex

Trial design and enrolment characteristics of LATA (long-acting treatment in adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa

Diana Anena, Elizabeth Chappell, Rashidah Nazzinda, Cecilia Kiilu et autres

0 citationsUCL Discovery (University College London)

Accès ouvert 2025 preprintOpenAlex

Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): a randomised, open-label, non-inferiority, 96-week trialevaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen (CAB/RPV) compared to daily oral therapy (DTG based TDF or TAF with 3TC or FTC backbone) in virologically suppressed adolescents living with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa

Diana Anena, Elizabeth Chappell, Rashidah Nazzinda, Cecilia Kiilu et autres

0 citationsSSRN Electronic Journal

Accès ouvert 2024 articleOpenAlex

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook, Howard Kynaston et autres

53 citationsThe Lancet

Accès ouvert 2023 conference-abstractOpenAlex

PA-675 Navigating the COVID-19 pandemic for participant recruitment and follow-up: experiences from the PediCAP clinical trial consortium

Andrew Kiggwe, Damalie Nalwanga, Abner Tagoola, Shabir A. Madhi et autres

0 citations

2014 conference-abstractOpenAlex

Prostate Adenocarcinoma: TransCutaneous Hormones, PR09 (PATCH): A randomized controlled trial of transdermal estrogen patches versus luteinising hormone releasing hormone agonists in locally advanced and metastatic prostate cancer.

Ruth E. Langley, Trinh Duong, Gordana Jovic, Abdulla Alhasso et autres

0 citationsJournal of Clinical Oncology

2014 conference-abstractOpenAlex

Bone density in men receiving androgen deprivation therapy for prostate cancer: A randomized comparison between transdermal estrogen and luteinising hormone-releasing hormone agonists.

Ruth E. Langley, Trinh Duong, Gordana Jovic, Fay Cafferty et autres

4 citationsJournal of Clinical Oncology

Accès ouvert 2013 conference-paperOpenAlex

Exploring the Whole Life Carbon Benefits of Insulation Materials in Housing Refurbishment

Simon Tucker, Ben Spittle

1 citationLiverpool John Moores University

2010 articleOpenAlex

DNA-Dependent Protein Kinase (DNA-PK) Inhibitors. Synthesis and Biological Activity of Quinolin-4-one and Pyridopyrimidin-4-one Surrogates for the Chromen-4-one Chemotype

Céline Cano, Olivier Barbeau, C. L. Bailey, Xiaoling Cockcroft et autres

45 citationsJournal of Medicinal Chemistry

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.